Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001415889-25-003823 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-12 | 2025-02-12 | TVTX | REED ELIZABETH E | SVP, GC, Corp. Sec | S - Sale+OE | $23.53 | -8,000 | 89.5K | -8% | -$188.2K |
| D | 2025-02-12 | 2025-02-10 | TVTX | REED ELIZABETH E | SVP, GC, Corp. Sec | M - OptEx | — | +8,000 | 97.5K | +9% | — |
| D | 2025-02-12 | 2025-02-10 | TVTX | REED ELIZABETH E | SVP, GC, Corp. Sec | M - OptEx | $0.00 | -8,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | S | D | 8,000 | $23.53 | 89,482 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-10 | M | A | 8,000 | — | 97,482 | D | — | — | (F2) Each PSU represents a contingent right to receive one share of the common stock of the Issuer. |
| 3 | Derivative | Performance-based restricted stock units | 2025-02-10 | M | D | 8,000 | $0.00 | 0 | D | — · — to — | 8,000 Common Stock | (F2) Each PSU represents a contingent right to receive one share of the common stock of the Issuer. |